Abuse pattern of analgesics in chronic daily headache: A study in the general population;Patrón de abuso de analgésicos en la cefalea crónica diaria: Un estudio en población general

Revista Clinica Espanola

Volumn 205, Issue 12, 2005, Pages 583-587

  Colas Chacartegui R ^a   Temprano Gonzalez R ^a   Gomez Arruza C ^a   Munoz Cacho P ^b   Pascual Gomez J ^c  

^a Centro de Salud de Santoña   (Spain)

^b Gerencia de Atención Primaria Santander Laredo   (Spain)

^c HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Analgesic abuse; Chronic daily headache

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; CAFFEINE; DEXKETOPROFEN; ERGOTAMINE DERIVATIVE; NAPROXEN; NON PRESCRIPTION DRUG; OPIATE; PARACETAMOL; PROPYPHENAZONE; PYRAZOLONE; TRAMADOL; TRIPTAN DERIVATIVE;

ANALGESIC AGENT ABUSE; ARTICLE; CHRONIC DAILY HEADACHE; DRUG ABUSE PATTERN; DRUG DETERMINATION; DRUG USE; FREQUENCY ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; POPULATION RESEARCH; QUESTIONNAIRE; SOCIAL PROBLEM; SPAIN;

EID: 32044438429     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0014-2565(05)72650-3     Document Type: Article

References (27)

1. Peters GA, Horton BT. Headache: with special reference to excessive use of ergotamine preparations and withdrawal effects. Mayo Clin Proc. 1951;26:214-26.
2. Kudrow L. Paradoxical effects or frequent analgesic use. Adv Neurol. 1982;33:335-41.
3. Rapoport AM, Weeks RE, Sheftell FD. Analgesic rebound headache: theoretical and practical implications. Cephalalgia. 1985;5 Suppl 3:448-9.
4. Mathew NT, Reuveni U, Pérez F. Transformed or evolutive migraine. Headache. 1987;27:102-6.
5. Mathew NT. Drug-induced headache. Neurol Clin North Am. 1990;8: 903-12.
6. Mathew NT, Kurman R, Pérez F. Drug induced refractory headache: clinical features and management. Headache. 1990;30:630-4.
7. Granella F, Farina S, Malferrari G, Manzoni GC. Drug abuse in chronic headache: a clinico-epidemiologic study. Cephalalgia. 1987;7:15-9.
8. Diener HC, Wilkinson M, editors. Drug induced headache. Berlin/Heidelberg/New York: Springer; 1988.
9. Pint LA, Trenti T. Does chronic use of sumatriptan induce dependence? Headache. 1994; 34: 600.
10. Catarci T, Fiacco F, Argentino C, Sette G, Cerbo R. Ergotamine-induced headache can be sustained by sumatriptan daily intake. Cephalalgia. 1994;14:374-5.
11. Limmroth V, Karazawa Z, Fritsche G, Diener HC. Headache after frequent use of serotonin agonists zolmitriptan and naratriptan. Lancet. 1999; 353:78.
12. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8 Suppl 7:1-96.
13. Messinger HB, Spierings ELH, Vicent AJP. Overlap of migraine and tension-type headache in the International Headache Classification. Cephalalgia. 1991;11:233-7.
14. Solomon S, Lipton RB, Newman LC. Evaluation of chronic daily headache comparison to criteria for chronic tension-type headache. Cephalalgia. 1992;12:365-8.
15. Sanin LC, Mathew NT, Bellmeyer LR, Ali S. The International Headache Society headache classification as applied to a headache clinic population. Cephalalgia. 1994;14:443-6.
16. Manzoni GC, Granella F, Sandrini G, Cavallani A, Zanferrari C, Nappi G. Classification of chronic daily headache by IHS criteria: limits and new proposals. Cephalalgia. 1995;15:37-43.
17. Silberstein SD, Lipton RB, Solomon S, Mathew NT. Classification of daily and near daily headaches: proposed revisions to the IHS criteria. Headache. 1994;34:1-7.
18. Silberstein SD, Lipton RB, Sliwnski M. Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology. 1996;47:871-5.
19. Mathew NT. Drug-induced headache. Neurol Clin North Am. 1990;8: 903-12.
20. Diener HC. A personal view of the classification and definition of drug dependence headache. Cephalalgia. 1993;13 Suppl 12:68-71.
21. Evers S, Suhr B, Bauer B, Grotemeyer KH, Husstedt IW. J Neurol. 1999;246:802-9.
22. Castillo J, Muñoz P, Guitera V, Pascual J. Epidemiology of chronic daily headache in the general population. Headache. 1999;39:190-6.
23. Marrugat J, Vila J, Pavesi M, Sanz F. Estimación del tamaño de la muestra en la investigación clínica y epidemiológica. Med Clin (Barc). 1998;111:267-76.
24. Colás R, Muñoz P, Temprano R, Gómez C, Pascual J. Chronic daily headache with analgesic overuse: epidemiology, and impact on quality of life. Neurology. Neurology. 2004;62:1338-42.
25. Guitera V, Muñoz P, Castillo J, Pascual J. Transformed migraine: a proposal for the modification of its diagnostic criteria based on recent epidemiological data. Cephalalgia. 1999;19:847-50
26. Guitera V, Muñoz P, Castillo J, Pascual J. Quality of life in chronic daily headache. A study in a general population. Neurology. 2002;58:1062-5.
27. Diener HC, Katasarva Z. Analgesic/abortive overuse and misuse in chronic daily headache. Current Pain and Headache Reports. 2001;5:545-50.